160 related articles for article (PubMed ID: 9752060)
1. [Recombinant factor VIIa (eptacog alfa): a new therapeutic option for patients with severe bleeding disorder due to inhibitory antibodies against a coagulation factor].
Turkstra F; Levi M; Koopman MM; Wester JP; Stoutenbeek CP; Briët E
Ned Tijdschr Geneeskd; 1998 Jun; 142(25):1464-7. PubMed ID: 9752060
[TBL] [Abstract][Full Text] [Related]
2. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
Key NS; Aledort LM; Beardsley D; Cooper HA; Davignon G; Ewenstein BM; Gilchrist GS; Gill JC; Glader B; Hoots WK; Kisker CT; Lusher JM; Rosenfield CG; Shapiro AD; Smith H; Taft E
Thromb Haemost; 1998 Dec; 80(6):912-8. PubMed ID: 9869160
[TBL] [Abstract][Full Text] [Related]
3. Recombinant factor VIIa.
Aitken MG
Emerg Med Australas; 2004; 16(5-6):446-55. PubMed ID: 15537408
[TBL] [Abstract][Full Text] [Related]
4. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
Brandsborg S; Sørensen B; Poulsen LH; Ingerslev J
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
[TBL] [Abstract][Full Text] [Related]
5. Recombinant factor VIIa for intracranial haemorrhage in a Jehovah's Witness with severe haemophilia A and factor VIII inhibitors.
Majumdar G; Savidge GF
Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1031-3. PubMed ID: 8148476
[TBL] [Abstract][Full Text] [Related]
6. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
[TBL] [Abstract][Full Text] [Related]
7. [Treatment and prevention of haemorrhage with recombinant activated factor VII, not only in hemophilia].
Levi M; Friederich PW; van der Meer J
Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2534-7. PubMed ID: 12532665
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting choice of hemostatic agent for the hemophilia patient with an inhibitor antibody.
Monahan PE; Aledort LM;
Am J Hematol; 2004 Dec; 77(4):346-50. PubMed ID: 15558804
[TBL] [Abstract][Full Text] [Related]
9. [Perioperative use of recombinant activated factor VII (rF VIIa) in a patient with hemophilia A having inhibitors].
Kawasaki Y; Saeki N; Kawamoto M; Yuge O; Fujii T
Masui; 2005 Aug; 54(8):926-8. PubMed ID: 16104555
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary embolism after sequential use of recombinant factor VIIa and activated prothrombin complex concentrate in a factor VIII inhibitor patient.
Rosenfeld SB; Watkinson KK; Thompson BH; Macfarlane DE; Lentz SR
Thromb Haemost; 2002 May; 87(5):925-6. PubMed ID: 12038803
[No Abstract] [Full Text] [Related]
11. Transplacental transfer of postpartum inhibitors to factor VIII.
Lulla RR; Allen GA; Zakarija A; Green D
Haemophilia; 2010 Jan; 16(1):14-7. PubMed ID: 19500168
[TBL] [Abstract][Full Text] [Related]
12. Acquired haemophilia--a therapeutic challenge.
Teh A; Leong KW; Bosco JJ; Koong PL; Jayaranee S
Med J Malaysia; 1995 Jun; 50(2):166-70. PubMed ID: 7565188
[TBL] [Abstract][Full Text] [Related]
13. Recombinant factor VIIa (eptacog alfa): a review of its use in congenital hemophilia with inhibitors, acquired hemophilia, and other congenital bleeding disorders.
Croom KF; McCormack PL
BioDrugs; 2008; 22(2):121-36. PubMed ID: 18345709
[TBL] [Abstract][Full Text] [Related]
14. [Refractory acquired hemophilia A successfully treated with CVP].
Kaneko H; Okada N; Matsui Y; Nishizawa M; Watanabe M; Miura Y; Tsudo M
Rinsho Ketsueki; 2009 Feb; 50(2):110-2. PubMed ID: 19265305
[TBL] [Abstract][Full Text] [Related]
15. Acquired haemophilia: dynamic whole blood coagulation utilized to guide haemostatic therapy.
Johansen RF; Sørensen B; Ingerslev J
Haemophilia; 2006 Mar; 12(2):190-7. PubMed ID: 16476097
[TBL] [Abstract][Full Text] [Related]
16. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.
Hedner U
Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747
[No Abstract] [Full Text] [Related]
17. [Acquired haemophilia A: a rare but life-threatening auto-immune disorder].
Twiss E; Franschman G; Regelink J; Zuidema W
Ned Tijdschr Geneeskd; 2010; 154():A1749. PubMed ID: 20619047
[TBL] [Abstract][Full Text] [Related]
18. Hemostasis in acquired hemophilia--role of intracavitary instillation of EACA.
Sahu S; Raipancholia R; Pardiwalla FK; Pathare AV
J Postgrad Med; 1996; 42(3):88-90. PubMed ID: 9715327
[TBL] [Abstract][Full Text] [Related]
19. Use of recombinant factor VIIa (NovoSeven) in a haemophilia A patient with inhibitor in Kuwait.
Kanyike FB; Abdul-Salam SA; Prakash B; Sharhan A; Wahib N; Youssef AH
Haemophilia; 1999 Jul; 5(4):273-5. PubMed ID: 10469183
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors in young boys with haemophilia.
Lusher JM
Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):457-68. PubMed ID: 11030045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
